These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11819858)

  • 1. Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.
    Wang W; Qin SK; Chen BA; Chen HY
    World J Gastroenterol; 2001 Oct; 7(5):702-5. PubMed ID: 11819858
    [No Abstract]   [Full Text] [Related]  

  • 2. Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Fischer-Fodor E; Pop T; Susman S; Mosteanu O; Petrushev B; Aldea M; Acalovschi M; Irimie A; Kacso G
    Hematol Oncol Stem Cell Ther; 2011; 4(2):60-6. PubMed ID: 21727766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of arsenic trioxide on human hepatocarcinoma in nude mice.
    Xu HY; Yang YL; Liu SM; Bi L; Chen SX
    World J Gastroenterol; 2004 Dec; 10(24):3677-9. PubMed ID: 15534931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
    Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Liu LX; Zhu AL; Chen W; Guo HX; Wang XQ; Liu ZH; Zhang TD; Jiang HC; Wu M
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):33-6. PubMed ID: 15774171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
    Wang SS; Zhang T; Wang XL; Hong L; Qi QH
    World J Gastroenterol; 2003 May; 9(5):930-5. PubMed ID: 12717832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of arsenic trioxide combined with cisplatin on the growth of human nasopharyngeal carcinoma cells and reversion of RASSF1A hympermethylation].
    Huang X; Wang X; Hu J; Zhou H; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(14):1061-5. PubMed ID: 25330645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of arsenic trioxide in comprehensive therapy of liver carcinoma].
    Li JT; Ou QJ; Wu YC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec; 23(12):931-2. PubMed ID: 14714369
    [No Abstract]   [Full Text] [Related]  

  • 11. [An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
    Liu L; Qin S; Chen H; Wang J; Chen H; Ma J; Liu W
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):367-9. PubMed ID: 11135700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A; Yue D; Liao D; Cheng L; Ma J; Wei Y; Tong A; Cheng P
    Oncol Rep; 2016 Dec; 36(6):3283-3290. PubMed ID: 27748945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P
    J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
    Chan JY; Siu KP; Fung KP
    Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
    Huang X; Wang X; Hu J; Zhou H; Zhou K; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):479-83. PubMed ID: 23898615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
    Tung JN; Cheng YW; Hsu CH; Liu TZ; Hsieh PY; Ting LL; Ko HL; Chang YJ; Chiou JF; Wu AT
    Ann Surg Oncol; 2011 May; 18(5):1492-500. PubMed ID: 21181559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Wei J; Ye C; Liu F; Wang W
    J Chemother; 2014 Dec; 26(6):348-52. PubMed ID: 25068185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide-responsive leukemia cutis in a patient with acute promyelocytic leukemia after ATRA treatment.
    Wang HX; Duan LN; Ji SQ; Guo ZK
    Leuk Lymphoma; 2006 Jul; 47(7):1438-40. PubMed ID: 16923589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.